FDA Approves Expanded Use of Adacel (Tdap) Vaccine for Repeat Vaccination

Article Link: FDA Approves Expanded Use of Adacel (Tdap) Vaccine for Repeat Vaccination

BRIDGEWATER, N.J., Jan. 14, 2019 /PRNewswire/ — The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat…

Source: FDA New Drug Approvals